Dry Powder Inhaler Market Size, By Product Type, By Distribution Channel, By Application Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI2489
Dry Powder Inhaler Market size is projected to experience significant growth from 2018 to 2024.
Dry powder Inhaler market size should witness significant growth due to rising incidences of lung disorders. Hereditary diseases and increasing pollution due to high emission of harmful chemicals are major reasons for chronic respiratory diseases that has shown an increasing demand for the dry powder inhalers. Improvised accuracy of dry powder inhalers and better results in comparison with alternative therapies is driving factor that will aid market growth.
Increase in elderly population base prone to respiratory infections will support market growth. Major cause of lung diseases in teenagers and adults is nicotine addiction. Increase in fluctuations of hormones due to changing lifestyle that may trigger the need for having an addiction will show increased demand for dry powder inhaler industry growth.
Dry powder inhaler industry has shown a lucrative growth due rising incidence of allergies, infections and other lung diseases. However, lack of awareness causing decrease in demand for dry powder inhalers amongst the population should affect market growth. Availability of substitutes with moisture resistance property that lacks in the dry powder inhalers can have an impact on the market.
Single dose dry powder inhalers make largest business segment due to increasing prevalence of pulmonary diseases and respiratory diseases. Increased concentrations of harmful compounds and allergens in air have given rise to allergic conditions that cause asthma and other infections. This business segment contributes majorly to market growth as it is affordable and developing nations with moderate or low healthcare expenditures can easily adopt to these inhalers.
Increase in number of prescriptions for dry powder inhalers by hospitals due to increase in rate of adoption shown by doctors affects market growth positively. Also, there has been a favorable growth in this business segment due to availability of these inhalers in the pharmacies and presence of strong distribution channels.
Asthma, arterial hypertension, respiratory diseases are the demand drivers for dry powder inhalers that ensures sufficient and accurate dosage to patients. This business segment will be contributing majorly thereby increasing market share for dry powder inhaler.
U.S. will drive the North America dry powder inhaler industry due to increasing prevalence of asthma and other respiratory diseases coupled with increasing geriatric population. Adoption of new technologies will further enhance value addition to dry powder inhaler devices.
Following U.S., UK and Germany have a huge market for dry powder inhaler devices. Lifestyle changes and rise in occurrence of allergies and infections amongst population has led to an increased demand for dry powder inhalers in the overall market in Europe. Industrialization and excessive use of chemicals has further increased occurrence of respiratory ailments in workers that has led to market development.
Some of the key industry players include Alkermes, Astra Zeneca, Boehringer Ingelheim, Cheisi, Cipla, GlaxoSmithKline, Hovione, Mankind, 3M, OPKO, Teva. Key players have undertaken strategic decisions to provide best quality devices and help market to grow in future. In 2013, GSK manufactured Ellipta that revolutionized inhalers market with improvised efficiency and greater accuracy. This was an initiator step taken by GSK and recently, there are many developments in product that has allowed market for dry powder inhaler devices to grow.
Dry Powder Inhaler Market by Product type, 2013-2024 (USD Million)
- Single dose dry powder inhaler
- Multi Dose Dry Powder Inhaler
Dry Powder Inhaler Market by Distribution Channel, 2013-2024 (USD Million)
- Hospitals and Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
Dry Powder Inhaler Market by Application, 2013-2024 (USD Million)
- Chronic Obstructive Pulmonary Disease
- Pulmonary Arterial Hypertension
Industry Impact forces
- Increasing geriatric population
- Increasing infections and lung disorders
- Changing lifestyle
- Better accuracy and ease of use
Industry pitfalls and challenges
- Availability of Substitutes
- Lack of awareness
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Boehringer Ingelheim
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.